Personal Information
Michael Dornish
Co-founder and Chief Scientific Officer
Over 15 years experience in biopolymers – alginate and chitosan – development of ultrapure products for biomedical applications. 2 years experience in development of radiopharmaceuticals for treating cancer. 14 years experience in cancer research, in vitro and in vivo technologies, drug development.
Specialties: EUROTOX registered toxicologist. Qualified Person (QP).
ASTM International Division F04 Tissue Engineered Medical Products, Task group for biomaterials – alginate, chitosan, hyaluronic acid.